Wave Life Sciences
WVE
82 hedge funds and large institutions have $95.4M invested in Wave Life Sciences in 2022 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 21 increasing their positions, 33 reducing their positions, and 16 closing their positions.
170% more call options, than puts
Call options by funds: $62K | Put options by funds: $23K
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
2% less ownership
Funds ownership: 80.4% → 78.39% (-2%)
9% less funds holding
Funds holding: 90 → 82 (-8)
36% less capital invested
Capital invested by funds: $149M → $95.4M (-$53.1M)
36% less repeat investments, than reductions
Existing positions increased: 21 | Existing positions reduced: 33
50% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 16
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
M28 Capital Management
Stamford,
Connecticut
|
+$5.11M |
| 2 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
+$1.02M |
| 3 |
Goldman Sachs
New York
|
+$757K |
| 4 |
6CM
683 Capital Management
New York
|
+$673K |
| 5 |
Renaissance Technologies
New York
|
+$411K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LGM
Logos Global Management
San Francisco,
California
|
-$2.51M |
| 2 |
DM
Deerfield Management
New York
|
-$1.74M |
| 3 |
SG Americas Securities
New York
|
-$810K |
| 4 |
Millennium Management
New York
|
-$799K |
| 5 |
Morgan Stanley
New York
|
-$591K |
WVE Hedge Fund Activity: Q1 2022 in Review
82 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Wave Life Sciences (WVE) for Q1 2022, worth a combined $95.4M — down 36% from $149M a quarter earlier.
Sellers outnumbered buyers: 16 funds closed out of WVE and 8 opened new positions — a net loss of 8 holders — while 33 trimmed existing stakes and 21 added.
The largest buyer was M28 Capital Management, adding an estimated $5.11M. The largest seller was Logos Global Management, exiting entirely with an estimated $2.51M sold.
- 82 institutional investors held Wave Life Sciences (WVE) as of Q1 2022, down from 90 in Q4 2021.
- Funds reported $95.4M of Wave Life Sciences stock for Q1 2022, down 36% quarter-over-quarter.
- 8 funds opened new Wave Life Sciences positions in Q1 2022 and 16 closed out, a net change of -8 holders.
- The largest Wave Life Sciences buyer in Q1 2022 was M28 Capital Management, an estimated $5.11M added.
- The largest Wave Life Sciences seller in Q1 2022 was Logos Global Management, an estimated $2.51M sold.
Based on aggregated 13F filings for Q1 2022.